What Prescription Drugs are in Your Future?
Reuters, the news service, published a list of prescription drugs that are predicted to likely to be the top sellers in 2014. For comparison purposes, the forecasts for the top sellers predicted for 2010 were also included.
|
|
Projected Sales 2010 |
||
|
Rank |
Brand (Indication) |
Company |
Sales ($bln) |
|
1 |
Lipitor (cholesterol) |
Pfizer |
11.7 |
|
2 |
Plavix (clotting) |
Sanofi Aventis |
9.6 |
|
3 |
Advair(asthma-COPD) |
GSK |
9.0 |
|
4 |
Remicade (arthritis) |
J&J |
7.4 |
|
5 |
Enbrel (arthritis) |
Pfizer |
7.0 |
|
6 |
Humira (arthritis) |
Abbott |
6.8 |
|
7 |
Avastin (cancer) |
Roche |
6.7 |
|
8 |
Rituxan (cancer) |
Roche |
6.1 |
|
9 |
Diovan (hypertension) |
Novartis |
6.0 |
|
10 |
Crestor (cholesterol) |
AstraZeneca |
5.8 |
|
Projected Sales 2014 |
|||
|
Rank |
Brand (Indication) |
Company |
Sales ($bln) |
|
1 |
Avastin (cancer) |
Roche |
8.9 |
|
2 |
Humira (arthritis) |
Abbott |
8.5 |
|
3 |
Enbrel (arthritis) |
Pfizer |
8.0 |
|
4 |
Crestor (cholesterol) |
AstraZeneca |
7.7 |
|
5 |
Remicade (arthritis) |
J&J |
7.6 |
|
6 |
Rituxan (cancer) |
Roche |
7.4 |
|
7 |
Lantus (diabetes) |
Sanofi Aventis |
7.1 |
|
8 |
Advair(asthma-COPD) |
GSK |
6.8 |
|
9 |
Herceptin (cancer) |
Roche |
6.4 |
|
10 |
Novolog (diabetes) |
Novo Nordisk |
5.7 |
A quick perusal of the list suggests that there will likely be a shift toward the use of injected biologics in 2014 as compared with orally bioavailable small molecule drugs.
This should come as no surprise since most major pharmaceutical companies have publicly announced that biologics and biotechnology drugs are the key to their future successes.
Until next time
Good Luck and Good Job Hunting!!!!!
